Depression of GABAergic inhibitory postsynaptic potentials (IPSPs) represents an important regulatory mechanism in mammalian brain. The present project will test the hypothesis that postsynaptic increases in intracellular calcium concentration ([Ca2+]i) resulting from physiological processes in hippocampal pyramidal cells depress GABAA IPSPs. Current-clamp and whole-cell voltage-clamp recordings will be made in the hippocampal slice preparation. The following specific aims are proposed: 1) To determine if increased [Ca2+]i in pyramidal cells depresses GABAA responses and GABAergic IPSPs and IPSCs. Preliminary data suggest that this is true. 2) To determine which of several possible sources of Ca2+i are effective in doing so. Voltage-dependent Ca2+ channels, ligand-gated Ca2+ influx, Ca2+ release from intracellular stores and ion exchange mechanisms will be investigated. 3) To identify the intracellular biochemical system or systems responsible for the Ca2+ effects. 4) To investigate the short- and long-term functional implications of the Ca2+ effect. Regulation of GABAergic IPSPs by Ca2+i implies that an important positive feedback interaction may exist between the GABAA system and the mechanisms of Ca2+ influx (e.g., voltage-dependent Ca2+ channels, NMDA- mediated responses, etc.) often influenced, directly or indirectly, by this system. This work is directly relevant for understanding the neurophysiology of epilepsy and of hippocampal long-term potentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS030219-03
Application #
3417200
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1991-09-30
Project End
1995-09-29
Budget Start
1993-09-30
Budget End
1994-09-29
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Reich, C G; Mohammadi, M H; Alger, B E (2008) Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J Psychopharmacol 22:769-77
Edwards, David A; Zhang, Longhua; Alger, Bradley E (2008) Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc Natl Acad Sci U S A 105:8142-7
Karson, Miranda A; Whittington, Kevin C; Alger, Bradley E (2008) Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology 54:117-28
Isokawa, Masako; Alger, Bradley E (2006) Ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus. J Neurophysiol 95:3001-11
Edwards, David A; Kim, Jimok; Alger, Bradley E (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J Neurophysiol 95:67-75
Reich, Christian G; Karson, Miranda A; Karnup, Sergei V et al. (2005) Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus. J Neurophysiol 94:4290-9
Heinbockel, Thomas; Brager, Darrin H; Reich, Christian G et al. (2005) Endocannabinoid signaling dynamics probed with optical tools. J Neurosci 25:9449-59
Reich, Christian G; Mason, Susanne E; Alger, Bradley E (2004) Novel form of LTD induced by transient, partial inhibition of the Na,K-pump in rat hippocampal CA1 cells. J Neurophysiol 91:239-47
Kim, Jimok; Alger, Bradley E (2004) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7:697-8
Brager, Darrin H; Luther, Paul W; Erdelyi, Ferenc et al. (2003) Regulation of exocytosis from single visualized GABAergic boutons in hippocampal slices. J Neurosci 23:10475-86

Showing the most recent 10 out of 32 publications